240 related articles for article (PubMed ID: 15159303)
1. Fertility intentions following testing for a BRCA1 gene mutation.
Smith KR; Ellington L; Chan AY; Croyle RT; Botkin JR
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):733-40. PubMed ID: 15159303
[TBL] [Abstract][Full Text] [Related]
2. Attitudes toward the genetic testing of children among adults in a Utah-based kindred tested for a BRCA1 mutation.
Hamann HA; Croyle RT; Venne VL; Baty BJ; Smith KR; Botkin JR
Am J Med Genet; 2000 May; 92(1):25-32. PubMed ID: 10797419
[TBL] [Abstract][Full Text] [Related]
3. Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing.
Smith KR; West JA; Croyle RT; Botkin JR
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):385-92. PubMed ID: 10207644
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with decisions about clinical BRCA1/2 testing.
Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.
Lerman C; Hughes C; Croyle RT; Main D; Durham C; Snyder C; Bonney A; Lynch JF; Narod SA; Lynch HT
Prev Med; 2000 Jul; 31(1):75-80. PubMed ID: 10896846
[TBL] [Abstract][Full Text] [Related]
6. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
[TBL] [Abstract][Full Text] [Related]
7. Familial effects of BRCA1 genetic mutation testing: changes in perceived family functioning.
Stroup AM; Smith KR
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):135-41. PubMed ID: 17220342
[TBL] [Abstract][Full Text] [Related]
8. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
Schwartz MD; Lerman C; Brogan B; Peshkin BN; Isaacs C; DeMarco T; Halbert CH; Pennanen M; Finch C
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
[TBL] [Abstract][Full Text] [Related]
9. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
10. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
Patenaude AF; Dorval M; DiGianni LS; Schneider KA; Chittenden A; Garber JE
J Clin Oncol; 2006 Feb; 24(4):700-6. PubMed ID: 16446344
[TBL] [Abstract][Full Text] [Related]
11. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
Geller G; Doksum T; Bernhardt BA; Metz SA
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
[TBL] [Abstract][Full Text] [Related]
12. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
13. Psychological distress and quality of life associated with genetic testing for breast cancer risk.
Smith AW; Dougall AL; Posluszny DM; Somers TJ; Rubinstein WS; Baum A
Psychooncology; 2008 Aug; 17(8):767-73. PubMed ID: 17992698
[TBL] [Abstract][Full Text] [Related]
14. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Jernström H; Lubinski J; Lynch HT; Ghadirian P; Neuhausen S; Isaacs C; Weber BL; Horsman D; Rosen B; Foulkes WD; Friedman E; Gershoni-Baruch R; Ainsworth P; Daly M; Garber J; Olsson H; Sun P; Narod SA
J Natl Cancer Inst; 2004 Jul; 96(14):1094-8. PubMed ID: 15265971
[TBL] [Abstract][Full Text] [Related]
15. Posttraumatic stress associated with cancer history and BRCA1/2 genetic testing.
Hamann HA; Somers TJ; Smith AW; Inslicht SS; Baum A
Psychosom Med; 2005; 67(5):766-72. PubMed ID: 16204436
[TBL] [Abstract][Full Text] [Related]
16. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
Struewing JP; Lerman C; Kase RG; Giambarresi TR; Tucker MA
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):169-73. PubMed ID: 7742725
[TBL] [Abstract][Full Text] [Related]
17. No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result.
Dorval M; Gauthier G; Maunsell E; Dugas MJ; Rouleau I; Chiquette J; Plante M; Laframboise R; Gaudet M; Bridge PJ; Simard J
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2862-7. PubMed ID: 16365001
[TBL] [Abstract][Full Text] [Related]
18. Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations.
Lawrence WF; Peshkin BN; Liang W; Isaacs C; Lerman C; Mandelblatt JS
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):475-81. PubMed ID: 11352857
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
van Dijk S; Timmermans DR; Meijers-Heijboer H; Tibben A; van Asperen CJ; Otten W
J Clin Oncol; 2006 Aug; 24(22):3672-7. PubMed ID: 16877736
[TBL] [Abstract][Full Text] [Related]
20. Disparities in BRCA testing: when insurance coverage is not a barrier.
Olaya W; Esquivel P; Wong JH; Morgan JW; Freeberg A; Roy-Chowdhury S; Lum SS
Am J Surg; 2009 Oct; 198(4):562-5. PubMed ID: 19800469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
